+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Lymphedema Treatment Market Share, Size, Trends, Industry Analysis Report, By Treatment Type, By Affected Area, By End-User , By Region; Segment Forecast, 2022 - 2030

  • PDF Icon

    Report

  • 118 Pages
  • April 2022
  • Region: Global
  • Polaris Market Research
  • ID: 5598583
The global Lymphedema treatment market size is expected to reach USD 1,735.36 million by 2030 according to a new study. The report “Lymphedema Treatment Market Share, Size, Trends, Industry Analysis Report, By Treatment Type, By Affected Area, By End-User (Hospital, Specialty Clinics, Ambulatory Surgical Centers, Others), By Regions; Segment Forecast, 2022 - 2030” gives a detailed insight into current market dynamics and provides analysis on future market growth.



The increasing number of individuals being affected by Lymphedema is anticipated to drive the growth of the Lymphedema cure industry. Additionally, with the growing prevalence of the disease, innovative and advanced treatments are being developed in order to minimize risk during cure are also surging. Furthermore, the increasing healthcare expenditure coupled with the growing innovation across the healthcare sector is further projected to drive the industry growth. In addition, the launch of new medical devices by pharmaceutical companies is also fueling industry growth across the globe.

Based on the type, the secondary Lymphedema segment is dominating the global industry and is anticipated to lead the industry over the forecasting period. Secondary Lymphedema is generally caused by damage to the Lymph system via cancer treatment through radiation therapy and surgery among others. According to the CDC (Centers for Disease Control & Prevention), the majority of the patients suffer from secondary Lymphedema. Thus, the presence of a large patient pool is anticipated to drive the growth of the segment.

The rising investment by government and private pharmaceutical companies towards R&D for drug discovery is anticipated to present huge industry growth opportunities. Additionally, the growing prevalence of cancer and other chronic diseases is anticipated to drive the growth of the industry. For instance, as per the International Agency for Research on Cancer (IARC), in 2018, there were nearly 17.0 million new cancer cases were recorded, which is likely to grow to 27.5 million new cancer cases by 2040 because of the growth and aging of the population. Thereby, the rising occurrence of cancer is further acts as catalyzing factor for the market growth.

Market participants such as Avet Pharmaceuticals Inc., AIROS Medical Inc., Bio-compression Systems, Cardinal Health, Essity (BSN medical GmbH), Convatec Inc., Huntleigh Healthcare Limited, Koya Medical, JUZO, Medi GmbH, Lohmann & Rauscher, Mego Afek ltd., PAUL HARTMANN, Smith+Nephew HERANTIS PHARMA Plc, SIGVARIS GROUP, Tactile medical, and ThermoTek are some of the key players operating in the global market.

Further, the companies are initiating collaborative initiatives in order to increase their market share. For instance, in August 2021, AIROS Medical, announced an exclusive US distribution deal for fist assist fa-1 compression devices, enabling the company to boost its market presence.

The publisher has segmented the lymphedema treatment market report on the basis of treatment type, affected area, end-user, and region:


Lymphedema Treatment, Treatment Type Outlook

  • Compression Therapy
  • Surgery
  • Drug Therapy
  • Laser Therapy
  • Others

Lymphedema Treatment, Affected Area Outlook

  • Lower extremity
  • Upper extremity
  • Genitalia

Lymphedema Treatment, End-User Outlook

  • Hospital
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Others

Lymphedema Treatment, Regional Outlook

  • North America
  • U.S.
  • Canada
  • Europe
  • France
  • Germany
  • UK
  • Italy
  • Netherlands
  • Spain
  • Austria
  • Asia Pacific
  • China
  • India
  • Japan
  • Malaysia
  • South Korea
  • Indonesia
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
Frequently Asked Questions about the Global Lymphedema Treatment Market

What is the estimated value of the Global Lymphedema Treatment Market?

The Global Lymphedema Treatment Market was estimated to be valued at $786.53 million in 2022.

What is the growth rate of the Global Lymphedema Treatment Market?

The growth rate of the Global Lymphedema Treatment Market is 9.5%, with an estimated value of $1735.36 million by 2030.

What is the forecasted size of the Global Lymphedema Treatment Market?

The Global Lymphedema Treatment Market is estimated to be worth $1735.36 million by 2030.

Who are the key companies in the Global Lymphedema Treatment Market?

Key companies in the Global Lymphedema Treatment Market include AIROS Medical Inc., Avet Pharmaceuticals Inc., Bio, compression Systems, Cardinal Health, Convatec Inc., Essity (BSN medical GmbH), Huntleigh Healthcare Limited and Koya Medical.

Table of Contents

1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
2.1. Market Highlights
3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources
4. Global Lymphedema Treatment Market Insights
4.1. Lymphedema Treatment - Industry Snapshot
4.2. Lymphedema Treatment Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Prevalence of lymphedema and cancer
4.2.1.2. Technological advancements in diagnostic imaging modalities
4.2.2. Restraints and Challenges
4.2.2.1. Short half-life of radiopharmaceuticals
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Lymphedema Treatment Market Industry Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis
5. Global Lymphedema Treatment Market, by Treatment Type
5.1. Key Findings
5.2. Introduction
5.2.1. Global Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
5.3. Compression Therapy
5.3.1. Global Lymphedema Treatment Market, by Compression Therapy, by Region, 2018 - 2030 (USD Million)
5.4. Surgery
5.4.1. Global Lymphedema Treatment Market, by Surgery, by Region, 2018 - 2030 (USD Million)
5.5. Drug Therapy
5.5.1. Global Lymphedema Treatment Market, by Drug Therapy, by Region, 2018 - 2030 (USD Million)
5.6. Laser Therapy
5.6.1. Global Lymphedema Treatment Market, by Laser Therapy, by Region, 2018 - 2030 (USD Million)
5.7. Others
5.7.1. Global Lymphedema Treatment Market, by Others, by Region, 2018 - 2030 (USD Million)
6. Global Lymphedema Treatment Market, by Affected Area
6.1. Key Findings
6.2. Introduction
6.2.1. Global Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
6.3. Lower extremity
6.3.1. Global Lymphedema Treatment Market, by Lower extremity, by Region, 2018 - 2030 (USD Million)
6.4. Upper extremity
6.4.1. Global Lymphedema Treatment Market, by Upper extremity, by Region, 2018 - 2030 (USD Million)
6.5. Genitalia
6.5.1. Global Lymphedema Treatment Market, by Genitalia, by Region, 2018 - 2030 (USD Million)
7. Global Lymphedema Treatment Market, by End-Use
7.1. Key Findings
7.2. Introduction
7.2.1. Global Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
7.3. Hospital
7.3.1. Global Lymphedema Treatment Market, by Hospital, by Region, 2018 - 2030 (USD Million)
7.4. Specialty Clinics
7.4.1. Global Lymphedema Treatment Market, by Specialty Clinics, by Region, 2018 - 2030 (USD Million)
7.5. Specialty Clinics
7.5.1. Global Lymphedema Treatment Market, by Specialty Clinics, by Region, 2018 - 2030 (USD Million)
7.6. Others
7.6.1. Global Lymphedema Treatment Market, by Others, by Region, 2018 - 2030 (USD Million)
8. Global Lymphedema Treatment Market, by Geography
8.1. Key findings
8.2. Introduction
8.2.1. Lymphedema Treatment Market Assessment, By Geography, 2018 - 2030 (USD Million)
8.3. Lymphedema Treatment Market - North America
8.3.1. North America: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
8.3.2. North America: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
8.3.3. North America: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
8.3.4. Lymphedema Treatment Market - U.S.
8.3.4.1. U.S.: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
8.3.4.2. U.S.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
8.3.4.3. U.S.: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
8.3.5. Lymphedema Treatment Market - Canada
8.3.5.1. Canada: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
8.3.5.2. Canada.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
8.3.5.3. Canada: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
8.4. Lymphedema Treatment Market - Europe
8.4.1. Europe: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
8.4.2. Europe.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
8.4.3. Europe: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
8.4.4. Lymphedema Treatment Market - UK
8.4.4.1. UK: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
8.4.4.2. UK.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
8.4.4.3. UK: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
8.4.5. Lymphedema Treatment Market - France
8.4.5.1. France: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
8.4.5.2. France.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
8.4.5.3. France: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
8.4.6. Lymphedema Treatment Market - Germany
8.4.6.1. Germany: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
8.4.6.2. Germany.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
8.4.6.3. Germany: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
8.4.7. Lymphedema Treatment Market - Italy
8.4.7.1. Italy: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
8.4.7.2. Italy.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
8.4.7.3. Italy: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
8.4.8. Lymphedema Treatment Market - Spain
8.4.8.1. Spain: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
8.4.8.2. Spain.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
8.4.8.3. Spain: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
8.4.9. Lymphedema Treatment Market - Netherlands
8.4.9.1. Netherlands: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
8.4.9.2. Netherlands.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
8.4.9.3. Netherlands: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
8.4.10. Lymphedema Treatment Market - Austria
8.4.10.1. Austria: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
8.4.10.2. Austria.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
8.4.10.3. Austria: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
8.5. Lymphedema Treatment Market - Asia Pacific
8.5.1. Asia Pacific: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
8.5.2. Asia Pacific.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
8.5.3. Asia Pacific: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
8.5.4. Lymphedema Treatment Market - China
8.5.4.1. China: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
8.5.4.2. China.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
8.5.4.3. China: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
8.5.5. Lymphedema Treatment Market - India
8.5.5.1. India: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
8.5.5.2. India.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
8.5.5.3. India: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
8.5.6. Lymphedema Treatment Market - Malaysia
8.5.6.1. Malaysia: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
8.5.6.2. Malaysia.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
8.5.6.3. Malaysia: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
8.5.7. Lymphedema Treatment Market - Japan
8.5.7.1. Japan: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
8.5.7.2. Japan.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
8.5.7.3. Japan: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
8.5.8. Lymphedema Treatment Market - Indonesia
8.5.8.1. Indonesia: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
8.5.8.2. Indonesia.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
8.5.8.3. Indonesia: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
8.5.9. Lymphedema Treatment Market - South Korea
8.5.9.1. South Korea: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
8.5.9.2. South Korea.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
8.5.9.3. South Korea: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
8.6. Lymphedema Treatment Market - Middle East & Africa
8.6.1. Middle East & Africa: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
8.6.2. Middle East & Africa.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
8.6.3. Middle East & Africa: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
8.6.4. Lymphedema Treatment Market - Saudi Arabia
8.6.4.1. Saudi Arabia: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
8.6.4.2. Saudi Arabia.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
8.6.4.3. Saudi Arabia: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
8.6.5. Lymphedema Treatment Market - UAE
8.6.5.1. UAE: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
8.6.5.2. UAE.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
8.6.5.3. UAE: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
8.6.6. Lymphedema Treatment Market - Israel
8.6.6.1. Israel: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
8.6.6.2. Israel.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
8.6.6.3. Israel: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
8.6.7. Lymphedema Treatment Market - South Africa
8.6.7.1. South Africa: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
8.6.7.2. South Africa.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
8.6.7.3. South Africa: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
8.7. Lymphedema Treatment Market - Latin America
8.7.1. Latin America: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
8.7.2. Latin America.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
8.7.3. Latin America: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
8.7.4. Lymphedema Treatment Market - Mexico
8.7.4.1. Mexico: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
8.7.4.2. Mexico.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
8.7.4.3. Mexico: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
8.7.5. Lymphedema Treatment Market - Brazil
8.7.5.1. Brazil: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
8.7.5.2. Brazil.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
8.7.5.3. Brazil: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
8.7.6. Lymphedema Treatment Market - Argentina
8.7.6.1. Argentina: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
8.7.6.2. Argentina.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
8.7.6.3. Argentina: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
9. Competitive Landscape
9.1. Expansion and Acquisition Analysis
9.1.1. Expansion
9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
10.1. AIROS Medical Inc.
10.1.1. Company Overview
10.1.2. Financial Performance
10.1.3. Product Benchmarking
10.1.4. Recent Development
10.2. Avet Pharmaceuticals Inc.
10.2.1. Company Overview
10.2.2. Financial Performance
10.2.3. Product Benchmarking
10.2.4. Recent Development
10.3. Bio-compression Systems
10.3.1. Company Overview
10.3.2. Financial Performance
10.3.3. Product Benchmarking
10.3.4. Recent Development
10.4. Cardinal Health
10.4.1. Company Overview
10.4.2. Financial Performance
10.4.3. Product Benchmarking
10.4.4. Recent Development
10.5. Convatec Inc.
10.5.1. Company Overview
10.5.2. Financial Performance
10.5.3. Product Benchmarking
10.5.4. Recent Development
10.6. Essity (BSN medical GmbH)
10.6.1. Company Overview
10.6.2. Financial Performance
10.6.3. Product Benchmarking
10.6.4. Recent Development
10.7. Huntleigh Healthcare Limited
10.7.1. Company Overview
10.7.2. Financial Performance
10.7.3. Product Benchmarking
10.7.4. Recent Development
10.8. JUZO
10.8.1. Company Overview
10.8.2. Financial Performance
10.8.3. Product Benchmarking
10.8.4. Recent Development
10.9. Koya Medical
10.9.1. Company Overview
10.9.2. Financial Performance
10.9.3. Product Benchmarking
10.9.4. Recent Development
10.10. Lohmann & Rauscher
10.10.1. Company Overview
10.10.2. Financial Performance
10.10.3. Product Benchmarking
10.10.4. Recent Development
10.11. Medi GmbH
10.11.1. Company Overview
10.11.2. Financial Performance
10.11.3. Product Benchmarking
10.11.4. Recent Development
10.12. Mego Afek ltd.
10.12.1. Company Overview
10.12.2. Financial Performance
10.12.3. Product Benchmarking
10.12.4. Recent Development
10.13. PAUL HARTMANN
10.13.1. Company Overview
10.13.2. Financial Performance
10.13.3. Product Benchmarking
10.13.4. Recent Development
10.14. SIGVARIS GROUP
10.14.1. Company Overview
10.14.2. Financial Performance
10.14.3. Product Benchmarking
10.14.4. Recent Development
10.15. Smith+Nephew HERANTIS PHARMA Plc
10.15.1. Company Overview
10.15.2. Financial Performance
10.15.3. Product Benchmarking
10.15.4. Recent Development
10.16. Tactile medical
10.16.1. Company Overview
10.16.2. Financial Performance
10.16.3. Product Benchmarking
10.16.4. Recent Development
10.17. ThermoTek
10.17.1. Company Overview
10.17.2. Financial Performance
10.17.3. Product Benchmarking
10.17.4. Recent Development

Companies Mentioned

  • AIROS Medical Inc.
  • Avet Pharmaceuticals Inc.
  • Bio-compression Systems
  • Cardinal Health
  • Convatec Inc.
  • Essity (BSN medical GmbH)
  • Huntleigh Healthcare Limited
  • JUZO
  • Koya Medical
  • Lohmann & Rauscher
  • Medi GmbH
  • Mego Afek ltd.
  • PAUL HARTMANN
  • SIGVARIS GROUP
  • Smith+Nephew HERANTIS PHARMA Plc
  • Tactile medical
  • ThermoTek.